Infected Endocarditis (IE) Mortality Risk Score

Estimates short‑term mortality in infective endocarditis using baseline clinical severity and infection characteristics.

Age (in years)
≤ 45045-60+261-70+3> 70+4
History of dialysis
No0Yes+3
Nosocomial IE
No0Yes+2
Prosthetic IE
No0Yes+1
Symptoms > 1 month before admission
Yes-1No0
Staph aureus
No0Yes+1
Viridans group strep
Yes-2No0
Aortic vegetation
No0Yes+1
Mitral vegetation
No0Yes+1
NYHA class 3 or 4 heart failure
No0Yes+3
Stroke
No0Yes+2
Paravalvular complication
No0Yes+2
Persistent bacteremia
No0Yes+2
Surgical treatment
Yes-2No0

사용 적응증

Used in adults with definite or suspected left‑sided IE at hospital presentation to estimate early (in‑hospital/30‑day) mortality risk and guide intensity of monitoring and timing of surgery. Clinical utility is rapid identification of high‑risk features consistently linked to mortality—heart failure, S. aureus etiology, renal dysfunction, large vegetations, and absence of indicated surgery 1 [Level II evidence]; 2 [Level II evidence].

통찰 및 주의사항

Start with factors consistently linked to higher mortality: abnormal mental status, moderate–severe heart failure, non‑viridans streptococcal pathogens (especially S. aureus), renal dysfunction, large vegetations >10 mm, stroke/hemorrhage, and withholding indicated surgery 1 [Level I evidence]; 2 [Level II evidence]; 3 [Level II evidence]. Cautions: scores often underperform in external validation, omit microbiology or frailty, and must not replace early surgical evaluation 4 [Level III evidence].